<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02362581</url>
  </required_header>
  <id_info>
    <org_study_id>3125055</org_study_id>
    <nct_id>NCT02362581</nct_id>
  </id_info>
  <brief_title>Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A</brief_title>
  <official_title>Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of prophylaxis and on-demand treatment in children with moderate to severe
      hemophilia A.

      This study determines to compare the efficacy of prophylaxis and on-demand treatment in
      moderate to severe hemophilia A children in King Chulalongkorn Memorial Hospital, Bangkok,
      Thailand
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of bleeding episodes require treatment</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>number of school days lost</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of admission days</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Joint scores</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life score</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Facter VIII concentration used</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Prophylaxis</condition>
  <condition>Hemophilia A</condition>
  <arm_group>
    <arm_group_label>On demand treatment, prophylaxis treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>On demand treatment arm:Patients received factorVIII concentrate(Hemofil M) when they had bleeding episodes.
Prophylaxis arm: patients received factorVIII concentrate (Hemofil M) 30-35 unit/kg once a week</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>prophylaxis treatment, on demand treatment</intervention_name>
    <arm_group_label>On demand treatment, prophylaxis treatment</arm_group_label>
    <other_name>Hemofil M</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 6 months to 18 years

          -  Diagnosis severe and moderate hemophilia A

        Exclusion Criteria:

          -  platelet &lt; 100,000/mm3

          -  No factor VIII inhibitor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darintr Sosothikul, Asso professer</last_name>
    <role>Principal Investigator</role>
    <affiliation>pediatric Hemato-Oncology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>pediatric Hemato-oncology department, King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Pratumwan</city>
        <state>Bangkok</state>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2015</study_first_submitted>
  <study_first_submitted_qc>February 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2015</study_first_posted>
  <last_update_submitted>February 9, 2015</last_update_submitted>
  <last_update_submitted_qc>February 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Darintr Sosothikul</investigator_full_name>
    <investigator_title>Pediatric Hematology/Oncology department</investigator_title>
  </responsible_party>
  <keyword>Prophylaxis treatment</keyword>
  <keyword>On demand treatment</keyword>
  <keyword>Severe hemophilia A</keyword>
  <keyword>Moderate hemophilia A</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Factor VIII</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

